Eric Oermann

AI researcher, neurosurgeon, entrepreneur, corgi owner

Eric Oermann is an Assistant Professor of Neurosurgery, Radiology, and Data Science at NYU Langone Health, where he integrates his expertise in artificial intelligence (AI) with clinical practice. His dual focus encompasses both clinical neurosurgery and AI research, aiming to enhance patient care through innovative technologies.

Education and Training

MD from Georgetown University (2013)
Residency in Neurological Surgery at the Icahn School of Medicine at Mount Sinai (2020)

Professional Background

Current Position: Assistant Professor at NYU Langone Health since July 2020.
Previous Roles:
- Scientific Advisor at X, the moonshot factory (2018-2020)
- Instructor at Mount Sinai Health System (2018-2020)
- Researcher at Verily Life Sciences (2016-2017)

Research Interests

Oermann's research primarily focuses on leveraging AI to solve practical challenges in healthcare. He is particularly interested in:

Machine learning applications in neurosurgery
Understanding and improving both human and artificial intelligence
Developing AI systems to assist in medical care for neurological conditions, including brain tumors and epilepsy.1 4

Achievements

Oermann has been recognized for his contributions to the field, including being named one of Forbes magazine's "30 Under 30" in Science and Healthcare during his residency. His work emphasizes interdisciplinary collaboration, involving various departments to advance AI applications in clinical settings.1 3 4

Publications and Contributions

He has authored numerous research papers focusing on topics such as brain tumor segmentation using machine learning and the deployment of AI in clinical environments. His lab aims to bridge the gap between AI research and real-world medical applications, addressing what he describes as the "last-mile problem" in healthcare technology deployment.2 4

In summary, Eric Oermann stands out as a leader at the intersection of neurosurgery and artificial intelligence, dedicated to improving patient outcomes through innovative research and clinical practice.